Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles - PubMed (original) (raw)
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles
K Aalto-Setälä et al. J Clin Invest. 1992 Nov.
Abstract
Hypertriglyceridemia is common in the general population, but its mechanism is largely unknown. In previous work human apo CIII transgenic (HuCIIITg) mice were found to have elevated triglyceride levels. In this report, the mechanism for the hypertriglyceridemia was studied. Two different HuCIIITg mouse lines were used: a low expressor line with serum triglycerides of approximately 280 mg/dl, and a high expressor line with serum triglycerides of approximately 1,000 mg/dl. Elevated triglycerides were mainly in VLDL. VLDL particles were 1.5 times more triglyceride-rich in high expressor mice than in controls. The total amount of apo CIII (human and mouse) per VLDL particle was 2 and 2.5 times the normal amount in low and high expressors, respectively. Mouse apo E was decreased by 35 and 77% in low and high expressor mice, respectively. Under electron microscopy, VLDL particles from low and high expressor mice were found to have a larger mean diameter, 55.2 +/- 16.6 and 58.2 +/- 17.8 nm, respectively, compared with 51.0 +/- 13.4 nm from control mice. In in vivo studies, radiolabeled VLDL fractional catabolic rate (FCR) was reduced in low and high expressor mice to 2.58 and 0.77 pools/h, respectively, compared with 7.67 pools/h in controls, with no significant differences in the VLDL production rates. In an attempt to explain the reduced VLDL FCR in transgenic mice, tissue lipoprotein lipase (LPL) activity was determined in control and high expressor mice and no differences were observed. Also, VLDLs obtained from control and high expressor mice were found to be equally good substrates for purified LPL. Thus excess apo CIII in HuCIIITg mice does not cause reduced VLDL FCR by suppressing the amount of extractable LPL in tissues or making HuCIIITg VLDL a bad substrate for LPL. Tissue uptake of VLDL was studied in hepatoma cell cultures, and VLDL from transgenic mice was found to be taken up much more slowly than control VLDL (P < 0.0001), indicating that HuCIIITg VLDL is not well recognized by lipoprotein receptors. Additional in vivo studies with Triton-treated mice showed increased VLDL triglyceride, but not apo B, production in the HuCIIITg mice compared with controls. Tissue culture studies with primary hepatocytes showed a modest increase in triglyceride, but not apo B or total protein, secretion in high expressor mice compared with controls. In summary, hypertriglyceridemia in HuCIIITg mice appears to result primarily from decreased tissue uptake of triglyceride-rich particles from the circulation, which is most likely due to increased apo CIII and decreased apo E on VLDL particles. the HuCIIITg mouse appears to be a suitable animal model of primary familial hypertriglyceridemia, and these studies suggest a possible mechanism for this common lipoprotein disorder.
Similar articles
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV. Ginsberg HN, et al. J Clin Invest. 1986 Nov;78(5):1287-95. doi: 10.1172/JCI112713. J Clin Invest. 1986. PMID: 3095375 Free PMC article. - Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
Aalto-Setälä K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL. Aalto-Setälä K, et al. J Lipid Res. 1996 Aug;37(8):1802-11. J Lipid Res. 1996. PMID: 8864964 - Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
Atger V, Beyne P, Frommherz K, Roullet JB, Drüeke T. Atger V, et al. Ann Biol Clin (Paris). 1989;47(8):497-501. Ann Biol Clin (Paris). 1989. PMID: 2690681 Review. - Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S. Takahashi S. J Atheroscler Thromb. 2017 Jun 1;24(6):552-559. doi: 10.5551/jat.RV17004. Epub 2017 Apr 19. J Atheroscler Thromb. 2017. PMID: 28428482 Free PMC article. Review.
Cited by
- Moderate-intensity continuous training reduces triglyceridemia and improves oxygen consumption in dyslipidemic apoCIII transgenic mice.
Teixeira Junior NR, Jimenes DR, Schultz C, Almeida DL, Mathias PCF, Berti JA. Teixeira Junior NR, et al. Braz J Med Biol Res. 2024 Jul 29;57:e13202. doi: 10.1590/1414-431X2024e13202. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 39082576 Free PMC article. - MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice.
Li C, Tian J, Liu N, Song D, Steer CJ, Han Q, Song G. Li C, et al. J Lipid Res. 2024 Jul;65(7):100576. doi: 10.1016/j.jlr.2024.100576. Epub 2024 Jun 10. J Lipid Res. 2024. PMID: 38866328 Free PMC article. - Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes.
Cervantes J, Koska J, Kramer F, Akilesh S, Alpers CE, Mullick AE, Reaven P, Kanter JE. Cervantes J, et al. JCI Insight. 2024 May 14;9(12):e177268. doi: 10.1172/jci.insight.177268. JCI Insight. 2024. PMID: 38743496 Free PMC article. - Role of APOC3 3238C/G, APOB 12669G/A and SCARB1 1050C/T polymorphisms, their expression in patients of HIV-associated lipodystrophy.
Singh H, Shyamveer, Jori C, Mahajan SD, Aalinkeel R, Kaliyappan K, Bhattacharya M, Parvez MK, Al-Dosari MS. Singh H, et al. Heliyon. 2024 May 1;10(9):e30519. doi: 10.1016/j.heliyon.2024.e30519. eCollection 2024 May 15. Heliyon. 2024. PMID: 38742060 Free PMC article. - Early cellular and molecular signatures correlate with severity of West Nile virus infection.
Lee HJ, Zhao Y, Fleming I, Mehta S, Wang X, Wyk BV, Ronca SE, Kang H, Chou CH, Fatou B, Smolen KK, Levy O, Clish CB, Xavier RJ, Steen H, Hafler DA, Love JC, Shalek AK, Guan L, Murray KO, Kleinstein SH, Montgomery RR. Lee HJ, et al. iScience. 2023 Nov 2;26(12):108387. doi: 10.1016/j.isci.2023.108387. eCollection 2023 Dec 15. iScience. 2023. PMID: 38047068 Free PMC article.
References
- Science. 1990 Aug 17;249(4970):790-3 - PubMed
- J Biol Chem. 1980 Nov 10;255(21):10464-71 - PubMed
- Biochim Biophys Acta. 1990 May 1;1044(1):20-5 - PubMed
- J Lipid Res. 1990 Apr;31(4):567-82 - PubMed
- J Biol Chem. 1990 Jun 25;265(18):10771-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials